STOPPIT-3

This study aims to find out if the drug antenatal corticosteroids (ACS) given to women with a twin pregnancy prior to a planned birth of twins after 35 weeks of pregnancy reduces breathing difficulties in the twin babies.

Stoppit 3 logo

Chief Investigator: Prof Sarah Stock/Dr Sarah Murray

Number and location of participating sites: UK – 50 sites

EudraCT number:  2021-002876-38

ISRCTN59959611

 

Funder: NIHR

 

Start and End date

Of grant award: 1 November 2021 - 31 October 2025

Of recruitment: Grant start date: 1 August 2022 - 31 April 2025

 

Current Status: Currently recruiting

 

Website: www.stoppitstudy.co.uk

 

UK GDPR Privacy Statement: information given within PIL consent

 

Sponsor: ACCORD https://www.accord.scot/

 

Chief Investigators: Prof Sarah Stock and Dr Sarah Murray

Email: STOPPIT.Trial@ed.ac.uk

Research Midwife: Indira Kemp

Contact address: Edinburgh Clinical Trials Unit, Usher Building, The University of Edinburgh, 5‒7 Little France Road, Edinburgh BioQuarter ‒ Gate 3, EDINBURGH EH16 4UX

ECTU Involvement: Trial management / Statistics / Health Economics / Database and randomisation service.

(UKCRC)

 

This article was published on